Employment letter agreements with executive officers
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Tom Frohlich
Also a director
Chief Executive Officer and President
|
50 | Not stated | $9,799,759 | |
|
Bradford Dahms
Chief Financial Officer and Treasurer
|
38 |
Since 2025
1 year
|
$4,131,991 | |
|
Elizabeth Balta
Chief Legal Officer and Corporate Secretary
|
56 |
Since 2026
this year
|
Not reported | |
|
Andrew King
President, Research and Development
|
47 |
Since 2026
this year
|
$4,541,804 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 28, 2026 · updated by the 8-K of Jun 26, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Eric Dobmeier
Board chair
|
57 |
2025
1 year
|
Not stated |
Nominating and Corporate Governance
|
Janux Therapeutics, Inc. | $226,935 | |
|
Tom Frohlich
CEO
|
50 |
2025
1 year
|
Not independent | None stated | None stated | Paid as CEO | |
|
Christopher Cain
|
42 |
2025
1 year
|
Not stated |
Nominating and Corporate Governance
|
Cogent Biosciences, Inc. | Not stated | |
|
Erin Lavelle
|
48 |
2025
1 year
|
Not stated |
Audit · Chair
|
None stated | $212,422 | |
|
Tomas Kiselak
|
39 |
2025
1 year
|
Not stated |
Compensation · Chair
|
Viridian Therapeutics, Inc. | $206,347 | |
|
Lawrence Klein
|
43 |
2025
1 year
|
Not stated |
Nominating and Corporate Governance · Chair
|
Oruka Therapeutics, Inc. | Not stated | |
|
Mark Eisner
Joined Jun 25, 2026
|
- | - | - |
Nominating and Corporate Governance Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Employment letter agreements with executive officers
Indemnification agreements with each director and senior officer, requiring indemnification to the fullest extent permitted by Nevada law
Loading...